2185 — Shanghai Bio-heart Biological Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.01bn
- HK$1.13bn
- CNY44.93m
Annual cashflow statement for Shanghai Bio-heart Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -410 | -231 | -189 | -93.3 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 325 | 118 | 72.7 | 32.7 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -16.9 | -48.5 | 45.7 | -67.1 | — |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -88.5 | -141 | -49 | -120 | — |
| Capital Expenditures | -34.7 | -30 | -18 | -47.1 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.972 | -70.6 | -10.9 | 1.11 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -33.7 | -101 | -28.9 | -46 | — |
| Financing Cash Flow Items | -7.27 | -2.15 | -0.561 | -0.322 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 384 | -35.2 | -5.82 | -2.44 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 255 | -257 | -81.9 | -167 | — |